Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
361
Liu C.-T., Chen C.-Y., Hsu C.-Y. et al. Risk of febuxostat-associated myopathy in
patients with CKD // Clin. J. Am. Soc. Nephrol. 2017. Vol. 12, N. 5. P. 744-750.
Liu X., Lou X., Cheng X. et al. Impact of metoprolol treatment on mental status of chronic heart failure
patients with neuropsychiatric disorders // Drug Des. Devel. Ther.
2017. Vol. 11. P. 305-312.
Liu G., Zheng X.X., Xu Y.L. et al. Effects of lipophilic statins for heart failure: a meta-analysis of 13
randomised controlled trials // Heart Lung. Circ. 2014. Vol. 23,
N. 10. P. 970-977.
Ljung R., Lagergren J., Bexelius T.S. et al. Increased risk of acute pancreatitis among tetracycline users in
a Swedish population-based case control study // Gut. 2012.
Vol. 61, N. 6. P. 873-876.
Lodato F., Azzaroli F., Girolamo M.D. et al. Proton pump inhibitors in cirrhosis: tradition or evidence
based practice? // World J. Gastroenterol. 2008. Vol. 14, N. 19.
P. 2980-2985.
Loffredo L., Perri L., Violi F. et al. Myocardial infarction and atrial fibrillation: Different impact of anti-IIa
vs anti-Xa new oral anticoagulants // Int. J. Cardiol. 2015.
Vol. 178. P. 8-9.
Loffredo L., Perri L., Violi F. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial
fibrillation: a meta-analysis of interventional trials // Dig. Liver Dis. 2015. Vol. 47, N. 5. P. 429-431.
Loke Y.K., Singh S. Risk of acute urinary retention associated with inhaled anticholinergics in patients
with chronic obstructive lung disease // Ther. Adv. Drug Saf. 2013. Vol. 4, N. 1. P. 19-26.
Lonborg J., Vejlstrup N., Kelbaek H. et al. Exenatide reduces reperfusion injury in patients with ST-
segment elevation myocardial infarction // Eur. Heart J. 2012.
Vol. 33. P. 1491-1499.
Lopez-Jimenez F., Bhatia S., Collazo-Clavell M.L. et al. Safety and efficacy of bariatric surgery in patients
with coronary artery disease // Mayo Clin. Proc. 2005.
Vol. 80, N. 9. P. 1157-1162.
Lotta L.A., Sharp S.J., Burgess S. et al. Association between low-density lipopro-tein cholesterol-
lowering genetic variants and risk of type 2 diabetes: a meta-analysis //
JAMA. 2016. Vol. 316, N. 13. P. 1383-1391.
Low A.S.L., Symmons D.P.M., Lunt M. et al. Relationship between exposure to tumour necrosis factor
inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid
arthritis // Ann. Rheum. Dis. 2017. Vol. 76.
P. 654-660.
Ludvigsson J.F., Ström P., Lundholm C. et al. Risk for congenital malformation with H1N1 influenza
vaccine: a cohort study with sibling analysis // Ann. Intern. Med.
Источник KingMed.info
362
2016. Vol. 165. P. 848-855.
Luijendijk H.J., van den Berg J.F., Hofman A. et al. β-Blockers and the risk of incident depression in the
elderly // J. Clin. Psychopharmacol. 2011. Vol. 31, N. 1. P. 45-50.
Luo H., Zhao L., Leung J. et al. Routine pre-procedural rectal indometacin versus selective post-
procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde
cholangiopancreatography // Lancet. 2016. Vol. 387. P. 2293-2301.
Luo J.C., Leu H.B., Hou M.C. et al. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis
patients // Am. J. Med. 2013. Vol. 126, N. 3. P. 264.e25-e32.
MacDonald M.R., Eurich D.T., Majumdar S.R. et al. Treatment of type 2 diabetes and outcomes in
patients with heart failure: anested case-control study from the U.K. General Practice Research
Database // Diabetes Care. 2010. Vol. 33, N. 6.
P. 1213-1218.
MacLaren R., Reynolds P.M., Allen R.R. Histamine-2 receptor antagonists vs proton pump inhibitors on
gastrointestinal tract hemorrhage and infectious complications in the intensive care unit // JAMA
Intern. Med. 2014. Vol. 174, N. 4.
P. 564-574.
Machino T., Tada H., Sekiguchi Y. et al. Prevalence and influence ofhyperthyroidism on the long-term
outcome of catheter ablation for drug-refractory atrial fibrillation // Circ. J. 2012. Vol. 76, N. 11. P. 2546-
2551.
Madelaire C., Gislason G., Kristensen S.L. et al. Low-dose aspirin in heart failure not complicated by
atrial fibrillation // JACC Heart Fail. 2018. Vol. 6, N. 2. P. 156-167.
Magee L.A., von Dadelszen P., Rey E. et al. Less-tight versus tight control of hypertension in pregnancy
// N. Engl. J. Med. 2015. Vol. 372. P. 407-417.
Maggioni A.P., Greene S.J., Fonarow G.C. et al. Effect of aliskiren on post-discharge outcomes among
diabetic and non-diabetic patients hospitalized for heart
failure: insights from the ASTRONAUT trial // Eur. Heart J. 2013. Vol. 34, N. 40. P. 3117-3127.
Magne J., Guinot B., Le Guyader A. et al. Relation between renin-angiotensin system blockers and
survival following isolated aortic valve replacement for aortic stenosis // Am. J. Cardiol. 2018. Vol. 121,
N. 4. P. 455-460.
Mahajan R., Lau D.H., Brooks A.G. et al. Electrophysiological, electroanatomical, and structural
remodeling of the atria as consequences of sustained obesity // J. Am.
Coll. Cardiol. 2015. Vol. 66, N. 1. P. 1-11.
Mahfoud F., Tunev S., Ewen S. et al. Impact of lesion placement on efficacy and safety of catheter-based
radiofrequency renal denervation // J. Am. Coll. Cardiol. 2015. Vol. 66, N. 16. P. 1766-1775.
Maisel W.H., Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and
rationale for therapy // Am. J. Cardiol. 2003. Vol. 91, N. 6. P. 2-8.
Majoor C.J., Kamphuisen P.W., Zwinderman A.H. et al. Risk of deep vein thrombosis and pulmonary
embolism in asthma // Eur. Respir. J. 2013. Vol. 42, N. 3.
Источник KingMed.info
363
P. 655-661.
Major R.W., Cheung C.K., Gray L.J., Brunskill N.J. Statins and cardiovascular primary prevention in CKD:
ameta-analysis // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10.
P. 732-739.
Makani H., Bangalore S., Romero J. et al. Peripheral edema associated with calcium channel blockers:
incidence and withdrawal rate - a meta-analysis of randomized trials // J. Hypertension. 2011. N. 29,
Vol. 7.
Makarounas-Kirchmann K., Glover-Koudounas S., Ferrari P. Results of a metaanalysis comparing the
tolerability of lercanidipine and other dihydropyridine calcium
channel blockers // Clin. Ther. 2009. Vol. 31, N. 8. P. 1652-1663.
Malek F., Ostadal P., Parenica J. et al. Uric acid, allopurinol therapy, and mortality in patients with acute
heart failure - results of the Acute HEartFAilure Database
registry // J. Crit. Care. 2012. Vol. 27. N. 6. P. 737.e11-e24.
Malhotra R., Nguyen H.A., Benavente O. et al. Association between more intensive vs less intensive
blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5. A systematic
review and meta-analysis // JAMA Intern. Med. 2017.
Vol. 177. P. 1498-1505.
Mandorfer M., Bota S., Schwabl P. et al. Nonselective βblockers increase risk for hepatorenal syndrome
and death in patients with cirrhosis and spontaneous bacterial peritonitis // Gastroenterology. 2014.
Vol. 146. P. 1680-1690.e1.
Manfrini O., Morrell C., Das R. et al. Effects of angiotensin-converting enzyme inhibitors and beta
blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography
// Am. J. Cardiol. 2014. Vol. 113. P. 1628-1633.
Mangner N., Crusius L., Haussig S. et al. Continued versus interrupted oral anti-coagulation during
transfemoral transcatheter aortic valve implantation and impact of postoperative anticoagulant
management on outcome in patients with atrial fibrillation // Am. J. Cardiol. 2019. Vol. 123. P. 1134-
1141.
Mann D., Fernandez S., Mondal Z. et al. Role of coronary angiography in the assessment of
cardiovascular risk in kidney transplant candidates // Am. J. Cardiol.
2016. Vol. 118, N. 5. P. 679-683.
Mannisto T., Mendola P., Vaarasmaki M. et al. Elevated blood pressure in pregnancy and subsequent
chronic disease risk // Circulation. 2013. Vol. 127, N. 6. P. 681-690.
Mansencal N., Mustafic H., Hauguel-Moreau M. et al. Occurrence of Atrial Fibrillation During
Dobutamine Stress Echocardiography // Am. J.. Cardiology. 2019.
Vol. 8. P. 1277-1282.
Marfella R., Sasso F.C., Siniscalchi M. et al. Brief episodes of silent atrial fibrillation predict clinical
vascular brain disease in type 2 diabetic patients // J. Am. Coll. Cardiol. 2013. Vol. 62. P. 525-530.
Источник KingMed.info
364
Mariusz G., Grzegorz S., Krzysztof W. et al. Comparison of invasive and non-invasive treatment
strategies in older patients with acute myocardial infarction complicated by cardiogenic shock // Am. J.
Cardiol. 2011. Vol. 107, N. 1. P. 30-36.
Marott S.C., Nielsen S.F., Benn M., Nordestgaard B.G. Antihypertensive treatment and risk of atrial
fibrillation: a nationwide study // Eur. Heart J. 2014. Vol. 35.
P. 1205-1214.
Marti S., Munoz X., Rios J. et al. Body weight and comorbidity predict mortality in COPD patients
treated with oxygen therapy // Eur. Respir. J. 2006. Vol. 27, N. 4.
P. 689-696.
Martin R.I.R., Pogoryelova O., Koref M.S. et al. Atrial fibrillation associated with ivabradine treatment:
meta-analysis of randomised controlled trials // Heart. 2014.
Vol. 100, N. 19. P. 1506-1510.
Masamune A., Nishimori I., Kikuta K. et al Randomised controlled trial of long-term maintenance
corticosteroid therapy in patients with autoimmune pancreatitis // Gut. 2017. Vol. 66. P. 487-494.
Masoudi F.A., Plomondon M.E., Magid D.J. et al. Renal insufficiency and mortality from acute coronary
syndromes // Am. Heart J. 2004. Vol. 147, N. 4.
P. 623-629.
Matsumoto Y., Mori Y., Kageyama S. et al. Spironolactone reduces cardiovascular and cerebrovascular
morbidity and mortality in hemodialysis patients // J. Am. Coll. Cardiol. 2014. Vol. 63, N. 6. P. 528-536.
Mattsson N., Sadjadieh G., Kumarathurai P. et al. Ambulatory cardiac arrhythmias in relation to mild
hypokalaemia and prognosis in community dwelling middle-aged
and elderly subjects // Europace. 2016. Vol. 18, N. 4. P. 585-591.
Mazidi M., Rezaie P., Gao H.K. et al. Effect of sodium-glucose cotransport-2 inhibitors on blood
pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43
randomized control trials with 22 528 patients // J. Am. Heart
Assoc. 2017. Vol. 6, N. 6. Article ID 004007.
Mazzanti A., Maragna R., Faragli A. et al. Gene-specific therapy with mexiletine reduces arrhythmic
events in patients with long QT syndrome type 3 // J. Am. Coll. Cardiol. 2016. Vol. 67, N. 9. P. 1053-
1058.
McAllister-Williams R.H., Baldwin D.S., Cantwell R. et al. British Association for Psychopharmacology
consensus guidance on the use of psychotropic medication preconception, in pregnancy and
postpartum 2017 // J. Psychopharmacol. 2017. Vol. 31,
N. 5. P. 519-552.
McCullough P.A., Agarwal M., Agrawal V. Review article: risks of coronary artery calcification in chronic
kidney disease: do the same rules apply? // Nephrology
(Carlton). 2009. Vol. 14, N. 4. P. 428-436.
Источник KingMed.info
365
McGettigan P., Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk:
an examination of sales and essential medicines lists in low-, middle-, and high-income countries //
PLoS Med. 2013. Vol. 10, N. 2. Article
ID e1001388.
McIntyre C. et al. Prescribing drugs in kidney disease // Brenner and Rector's the Kidney. 9
th
ed.
Philadelphia, Pa : Saunders; Elsevier, 2012. Ch. 63. P. 2258-2291.
McKinney J.S., Kostis W.J. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31
randomized controlled trials // Stroke. 2012. Vol. 43, N. 8.
P. 2149-2156.
McLean-Tooke A., Aldridge C., Waugh S. et al. Methotrexate, rheumatoid arthritis and infection risk:
what is the evidence? // Rheumatology (Oxford). 2009. Vol. 48,
N. 8. P. 867-871.
McMullan C.J., Borgi L., Fisher N. et al. Effect of uric acid lowering on renin-angiotensin-system
activation and ambulatory BP: a randomized controlled trial //
Clin. J. Am. Soc. Nephrol. 2017. Vol. 12, N. 5. P. 807-816.
Mehta S.H., Brancati F.L., Sulkowski M.S. Prevalence of type 2 diabetes mellitus among persons with
hepatitis C virus infection in the United States // Ann. Intern. Med.
2000. Vol. 133. P. 592-599.
Meijer W.J., van Noortwijk A.G., Bruinse H.W., Wensing A.M. Influenza virus infection in pregnancy: a
review // Acta Obstet. Gynecol. Scand. 2015. Vol. 94, N. 8.
P. 797-819.
Mendez-Sanchez N., Bahena-Aponte J., Chavez-Tapia N.C. et al. Strong association between gallstones
and cardiovascular disease // Am. J. Gastroenterol. 2005.
Vol. 100, N. 4. P. 827-830.
Mentz R.J., Schulte P.J., Fleg J.L. et al. Clinical characteristics, response to exercise training, and
outcomes in patients with heart failure and chronic obstructive pulmonary
disease // Am. Heart J. 2013. Vol. 165, N. 2. P. 193-199.
Merzon E., Weiss N.S., Lustman A.J. et al. Statin administration and risk of cho-lecystectomy: a
population-based case-control study // Expert Opin. Drug Saf. 2010.
Vol. 9, N. 4. P. 539-543.
Micha R., Imamura F., von Ballmoos M.W. et al. Systematic review and meta-analysis of methotrexate
use and risk of cardiovascular disease // Am. J. Cardiol. 2011.
Vol. 108, N. 9. P. 1362-1370.
Michos E.D., Wilson L.M., Yeh H. et al. Prognostic value of cardiac troponin in patients with chronic
kidney disease without suspected acute coronary syndrome: asystematic review and meta-analysis //
Ann. Intern. Med. 2014. Vol. 161. P. 491-501.
Источник KingMed.info
366
Middleton T.L., Wong J., Molyneaux L. et al. Cardiac effects of sulfonylurea-related hypoglycemia //
Diabetes Care. 2017. Vol. 40, N. 5. P. 663-670.
Mikhaylov EN, Orshanskaya VS, Lebedev AD, et al. Catheter ablation of paroxysmal atrial fibrillation in
patients with previous amiodarone-induced hyperthyroidism: a case-control study. J Cardiovasc
Electrophysiol. 2013;24(8):888-93.
Milavec-Puretić V., Mance M., Ceović R., Lipozenčić J. Drug induced psoriasis //
Acta Dermatovenerol. Croat. 2011. Vol. 19, N. 1. P. 39-42.
Miles R.H., Passman R., Murdock D.K. Comparison of effectiveness and safety of ranolazine versus
amiodarone for preventing atrial fibrillation after coronary artery
bypass grafting // Am. J. Cardiol. 2011. Vol. 108. P. 673-676.
Miller C.S., Grandi S.M., Shimony A. et al. Meta-analysis of efficacy and safety of new oral
anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation //
Am. J. Cardiol. 2012. Vol. 110, N. 3. P. 453-460.
Mills E.J., O'Regan C., Eyawo O. et al. Intensive statin therapy compared with moderate dosing for
prevention of cardiovascular events: a meta-analysis of >40 000
patients // Eur. Heart J. 2011. Vol. 32, N. 11. P. 1409-1415.
Mitani G.M., Steinberg I., Lien E.J. et al. The pharmacokinetics of antiarrhyth-mic agents in pregnancy
and lactation // Clin. Pharmacokinet. 1987. Vol. 12, N. 4.
P. 253-291.
Mitchell J.E., Hellkamp A.S., Mark D.B. et al. Thyroid function in heart failure and impact on mortality //
JACC Heart Fail. 2013. Vol. 1. P. 48-55.
Modin D., Jorgensen M., Gislason G. et al. Influenza vaccine in heart failure //
Circulation. 2019. Vol. 5. P. 575-586.
Molnar M.Z., Kalantar-Zadeh K., Lott E.H. et al. Angiotensin-converting enzyme inhibitor, angiotensin
receptor blocker use, and mortality in patients with chronic kidney disease // J. Am. Coll. Cardiol. 2014.
Vol. 63, N. 7. P. 650-658.
Monami M., Ahrén B., Dicembrini I., Mannucci E. Dipeptidyl peptidase-4 inhibitors and cardiovascular
risk: a meta-analysis of randomized clinical trials // Diabetes
Obes. Metab. 2013. Vol. 15, N. 2. P. 112-120.
Monami M., Dicembrini I., Antenore A. et al. Dipeptidyl peptidase-4 inhibitors and bone fractures //
Diabetes Care. 2011. Vol. 34, N. 11. P. 2474-2476.
Morales D.R., Guthrie B., Lipworth B.J. et al. NSAID-exacerbated respiratory disease: a meta-analysis
evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity // Allergy.
2015. Vol. 70, N. 7. P. 828-835.
Morin L., Vetrano D.L., Rizzuto D. et al. Choosing wisely? Measuring the burden of medications in older
adults near the end of life: nationwide, longitudinal cohort
study // Am. J. Med. 2017. Vol. 130, N. 8. P. 927-936.
Источник KingMed.info
367
Morisco F., Castiglione F., Rispo A. et al. Effect of immunosuppressive therapy on patients with
inflammatory bowel diseases and hepatitis B or C virus infection //
J. Viral. Hepat. 2013. Vol. 20, N. 3. P. 200-208.
Mossello E., Pieraccioli M., Nesti N. et al. Effects of low blood pressure in cognitively impaired elderly
patients treated with antihypertensive drugs // JAMA
Intern. Med. 2015. Vol. 175, N. 4. P. 578-585.
Moua T., Wood K. COPD and PE: a clinical dilemma // Int. J. Chron. Obstruct.
Pulmon. Dis. 2008. Vol. 3, N. 2. P. 277-284.
Muka T. et al. Association of age at onset of menopause and time since onset of menopause with
cardiovascular outcomes, intermediate vascular traits, and all-cause mortality. A systematic review and
meta-analysis // JAMA Cardiol. 2016. Vol. 1, N. 7.
P. 767-776.
Mulnier H.E., Seaman H.E., Raleigh V.S. et al. Risk of myocardial infarction in men and women with type
2 diabetes in the UK: a cohort study using the General
Practice Research Database // Diabetologia. 2008. Vol. 51, N. 9. P. 1639-1645.
Musso G., Cassader M., Paschetta E., Gambino R. Thiazolidinediones and advanced liver fibrosis in
nonalcoholic steatohepatitis. A meta-analysis // JAMA
Intern. Med. 2017. Vol. 177, N. 5. P. 633-640.
Na K.S., Lee K.J., Lee J.S. et al. Efficacy of adjunctive celecoxib treatment for patients with major
depressive disorder: a meta-analysis // Prog. Neuropsychopharmacol. Biol.
Psychiatry. 2014. Vol. 48. P. 79-85.
Nadir M.A., Wei L., Elder D.H. et al. Impact of renin-angiotensin system blockade therapy on outcome
in aortic stenosis // J. Am. Coll. Cardiol. 2011. Vol. 58. P. 570-576.
Narayan P., Khan M.W., Das D. et al. Carotid artery screening at the time of coronary artery bypass -
does it influence neurological outcomes? // Int. J. Cardiol. 2017.
Vol. 243. P. 140-144.
Nard F.D., Todoerti M., Grosso V. et al. Risk of hepatitis B virus reactivation in rheumatoid arthritis
patients undergoing biologic treatment: Extending perspective
from old to newer drugs // World J. Hepatol. 2015. Vol. 7, N. 3. P. 344-361.
Narum S., Westergren T., Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic
review and meta-analysis // BMJ Open. 2014. Vol. 4, N. 5. Article
ID e004587.
Natsuaki M., Furukawa Y., Morimoto T. et al. Renal function and effect of statin therapy on
cardiovascular outcomes in patients undergoing coronary revasculariza-
tion // Am. J. Cardiol. 2012. Vol. 110, N. 11. P. 1568-1577.
Источник KingMed.info
368
Navarese E.P., Buffon A., Andreotti F. et al. Meta-analysis of impact of different types and doses of
statins on new-onset diabetes mellitus // Am. J. Cardiol. 2013.
Vol. 111, N. 8. P. 1123-1130.
Nawathe A., Ariyarajah V., Apiyasawat S. et al. Correlation of echocardiographic left atrial abnormality
with myocardial ischemia during myocardial perfusion assessment in the presence of known left
ventricular hypertrophy // Am. J. Cardiol. 2013. Vol. 112, N. 3. P. 416-419.
Nauck M.A., Tornoe K., Rasmussen S. et al. Cardiovascular outcomes in patients who experienced a
myocardial infarction while treated with liraglutide versus placebo in
the LEADER trial // Diab. Vasc. Dis. Res. 2018. Vol. 15, N. 5. P. 465-468.
Ndrepepa G., Braun S., Cassese S. et al. C-reactive protein and prognosis in women and men with
coronary artery disease after percutaneous coronary intervention //
Cardiovasc. Revasc. Med. 2013. Vol. 14, N. 5. P. 264-269.
Neefs J., van den Berg N.W.E., Limpens J. et al. Aldosterone pathway blockade to prevent atrial
fibrillation: a systematic review and meta-analysis // Int. J. Cardiol. 2017.
Vol. 231. P. 155-161.
Neimann A.L., Shin D.B., Wang X. et al. Prevalence of cardiovascular risk factors
in patients with psoriasis // J. Am. Acad. Dermatol. 2006. Vol. 55, N. 5. P. 829-835.
Nery F., Correia S., Macedo C. et al. Nonselective beta-blockers and the risk of portal vein thrombosis in
patients with cirrhosis: results of a prospective longitudinal
study // Aliment. Pharmacol. Therap. 2019. Vol. 5. P. 582-588.
Niccoli G., Giubilato S., Di Vito L. et al. Severity of coronary atherosclerosis in patients with a first acute
coronary event: a diabetes paradox // Eur. Heart J. 2013.
Vol. 34, N. 10. P. 729-741.
Nichols G.A., Joshua-Gotlib S., Parasuraman S. Glycemic control and risk of cardiovascular disease
hospitalization and all-cause mortality // J. Am. Coll. Cardiol.
2013. Vol. 62, N. 2. P. 121-127.
Nidorf S.M., Eikelboom J.W., Budgeon C.A., Thompson P.L. Low-dose colchicine for secondary
prevention of cardiovascular disease // J. Am. Coll. Cardiol. 2013. Vol. 61,
N. 4. P. 404-410.
Nielsen O.W., Sajadieh A., Sabbah M. et al. Assessing optimal blood pressure in patients with
asymptomatic aortic valve stenosis. The SEAS study // Circulation. 2016.
Vol. 134, N. 6. P. 455-468.
Nielsen P.B., Larsen T.B., Skjoth F., Lip G.Y.H. Outcomes associated with resuming warfarin treatment
after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation // JAMA
Intern. Med. 2017. Vol. 177, N. 4. P. 563-570.
Nimmo C., Wright M., Goldsmith D. Management of atrial fibrillation in chronic kidney disease: double
trouble // Am. Heart J. 2013. Vol. 166, N. 2. P. 230-239.
Источник KingMed.info
369
Ninkovic V.M., Ninkovic S.M., Miloradovic V. et al. Prevalence and risk factors for prolonged QT interval
and QT dispersion in patients with type 2 diabetes // Acta Diabetol. 2016. Vol. 53, N. 5. P. 737-744.
Nissen S.E., Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction
and cardiovascular mortality // Arch. Intern. Med. 2010.
Vol. 170, N. 14. P. 1191-201.
Nistri S., Olivotto I., Maron M.S. et al. b-Blockers for prevention of exercise-induced left ventricular
outflow tract obstruction in patients with hypertrophic cardiomyopathy // Am. J. Cardiol. 2012. Vol.
110, N. 5. P. 715-719.
Nita A.L., Mohit A.L., Larisa C. et al. Warfarin dosing in patients with impaired kidney function // Am. J.
Kidney Dis. 2010. Vol. 56, N. 5. P. 823-831.
Niu Q., Wang Z., Zhang Y. et al. Combination use of clopidogrel and proton pump inhibitors increases
major adverse cardiovascular events in patients with coronary artery disease: a meta-analysis // J.
Cardiovasc. Pharmacol. Ther. 2016 Aug 10. pii:
1074248416663647.
Nochaiwong S., Ruengorn C., Awiphan R. et al. Efficacy and safety of warfarin in dialysis patients with
atrial fibrillation: a systematic review and meta-analysis // Open
Heart. 2016. Vol. 3, N. 1. e000441.
Noman A., Ang D., Ogston S. et al. Effect of high-dose allopurinol on exercise in patients with chronic
stable angina: a randomised, placebo controlled crossover trial //
Lancet. 2010. Vol. 375. P. 2161-2167.
Nordlund J.R., Pasquale L.R., Robin A.L. et al. The cardiovascular, pulmonary, and ocular hypotensive
effects of 0.2% brimonidine // Arch. Ophthalmol. 1995.
Vol. 113, N. 1. P. 77-83.
Noviani M., Wasserman S., Clowse M.E. et al. Breastfeeding in mothers with systemic lupus
erythematosus // Lupus. 2016. Vol. 25, N. 9. P. 973-979.
Novodvorsky P., Bernjak A., Chow E. et al. Diurnal differences in risk of cardiac arrhythmias during
spontaneous hypoglycemia in young people with type 1 diabetes //
Diabetes Care. 2017. Vol. 40, N. 5. P. 655-662.
Nucifora G., Schuijf J.D., Tops L.F. et al. Prevalence of coronary artery disease assessed by multislice
computed tomography coronary angiography in patients with paroxysmal or persistent atrial
fibrillation // Circ. Cardiovasc. Imaging. 2009. Vol. 2,
N. 2. P. 100-106.
Nunes B.P., Flores T.R., Mielke G.I. et al. Multimorbidity and mortality in older adults: a systematic
review and meta-analysis // Arch. Gerontol. Geriatr. 2016. Vol. 67.
P. 130-138.
O'Neil P., Birkenfeld A., McGowan B. et al. Efficacy and safety of semaglutide compared with liraglutide
and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active
controlled, dose-ranging, phase 2 trial // Lancet. 2018. Vol. 392, N. 10148. P. 637-649.
Источник KingMed.info
370
Oderda L.H., Young J.R., Asche C.V., Pepper G.A. Psychotropic-related hip fractures: meta-analysis of
first-generation and second-generation antidepressant and antipsychotic drugs // Ann. Pharmacother.
2012. Vol. 46, N. 7-8. P. 917-928.
Olesen J.B., Lip G.Y.H., Kamper A.L. et al. Stroke and bleeding in atrial fibrillation with chronic kidney
disease // N. Engl. J. Med. 2012. Vol. 367, N. 7. P. 625-635.
Olesen J.B., Lip G.Y.H., Lane D.A. et al. Vascular disease and stroke risk in atrial fibrillation: anationwide
cohort study // Am. J. Med. 2012. Vol. 125, N. 8. P. 826.
Olesen K., Steensig K., Madsen M. et al. Comparison of frequency of ischemic stroke in patients with
versus without coronary heart disease and without atrial fibrillation // Am. J. Cardiol. 2019. Vol. 1. P.
153-158.
Ornello R., Degan D., Tiseo C. et al. Distribution and temporal trends from 1993 to 2015 of ischemic
stroke subtypes // Stroke. 2018. Vol. 4. P. 814-819.
Orriols L., Delorme B., Gadegbeku B. et al. Prescription medicines and the risk of road traffic crashes: a
French registry-based study // PLoS Med. 2010. Vol. 7, N. 11.
Article ID e1000366.
Ortega F.B., Lee D.C., Katzmarzyk P.T. et al. The intriguing metabolically healthy but obese phenotype:
cardiovascular prognosis and role of fitness // Eur. Heart J. 2013.
Vol. 34, N. 5. P. 389-397.
Oudit G.Y., Bakal J.A., McAlister F.A., Ezekowitz J.A. Use of oral proton pump inhibitors is not associated
with harm in patients with chronic heart failure in an ambulatory setting // Eur. J. Heart Fail. 2011. Vol.
13, N. 11. P. 1211-1215.
Ouyang A.-J., Lv Y.-N., Zhong H.-L. et al. Meta-analysis of digoxin use and risk of mortality in patients
with atrial fibrillation // Am. J. Cardiol. 2015. Vol. 115. P. 901-906.
Overvad T.F., Rasmussen L.H., Skjoth F. et al. Body mass index and adverse events in patients with
incident atrial fibrillation // Am. J. Med. 2013. Vol. 126, N. 7. P. 640.
e9-e17.
Palmer S.C., Craig J.C., Navaneethan S.D. et al. Benefits and harms of statin therapy for persons with
chronic kidney disease. A systematic review and meta-analysis //
Ann. Intern. Med. 2012. Vol. 157, N. 4. P. 263-275.
Palmer S.C., Di Micco L., Razavian M. et al. Antiplatelet agents for chronic kidney
disease // Cochrane Database Syst. Rev. 2013. Vol. 2. CD008834.
Palmer S.C., Mavridis D., Navarese E. et al. Comparative efficacy and safety of blood pressure-lowering
agents in adults with diabetes and kidney disease: a network meta-analysis // Lancet. 2015. Vol. 385. P.
2047-2056.
Palmerini T., Biondi-Zoccai G., Reggiani L. et al. Risk of stroke with coronary artery bypass graft surgery
compared with percutaneous coronary intervention // J. Am.
Coll. Cardiol. 2012. Vol. 60, N. 9. P. 798-805.
Соседние файлы в папке Библиотека им академика М.И. Перельмана